Three of the country's largest pharmacy chains will have to pay $650.5 million over the next 15 years to two Ohio counties for their role in the opioid epidemic, a U.S. federal judge has ordered.
Aug 18, 2022
0
9
When I agreed to lead the Stanford-Lancet Commission on the North American Opioid Crisis, I knew I was striding into a combat zone. For the past quarter century, the medical community—as well as the rest of the country—has ...
Aug 12, 2022
0
50
"Despite the prevalence and societal costs of pain in the United States, investment in pain medication development is low, due in part to poor understanding of the probability of successful development of such medications," ...
Jun 21, 2022
1
138
Federal guidelines geared toward curbing the overprescription of opioids have modestly reduced their use after medical procedures to implant pacemakers and other heart devices, new research shows.
May 2, 2022
0
10
Medication-assisted treatment is among the most effective approaches to treat opioid dependency, but not as many Ohio clinicians who could be administering drugs like buprenorphine or naltrexone are doing so, found a recent ...
Mar 16, 2022
0
3
A study from the University at Albany School of Public Health found that school-based health center providers lack the training and confidence to successfully deliver opioid misuse interventions.
Mar 10, 2022
0
17
If you've ever had a root canal or tooth extraction, you might have been handed a prescription for Vicodin or another opioid painkiller to help you recover after your procedure.
Feb 9, 2022
0
7
(HealthDay)—Fundamental reform of regulatory systems is needed to address the opioid crisis in North America and beyond, according to recommendations from a Commission report published online Feb. 2 in The Lancet.
Feb 4, 2022
0
26
Without evidence-based public health policies that treat drug addiction as a chronic condition and prioritize prevention, the number of deaths from opioid overdoses in North America is predicted to grow exponentially, adding ...
Feb 3, 2022
0
5
(HealthDay)—The COVID-19 pandemic has shaken up the U.S. opioid crisis in ways bad and good, increasing the risk of use and overdose but also spurring innovative approaches to treatment.
Oct 1, 2021
0
3
